Evidence map›Paper›PMID 34921636›Full record

ArticleCellular and molecular life sciences : CMLS2021

TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes.

Hyunseung Sun, Eunmi Kim, Jihye Ryu, Hyejin Lee, Eun-Ae Shin, Minhyeong Lee, Haesong Lee, Jeong-Hoon Lee, Jung-Hwan Yoon, Dae-Geun Song and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. SLAM family-mediated crosstalk between tumor and immune cells in the tumor microenvironment: a promising biomarker and a potential therapeutic target for immune checkpoint therapies.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Hyunseung Sun *Department of Pharmacy, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Eunmi Kim *Department of Pharmacy, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Jihye RyuDepartment of Pharmacy, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Hyejin LeeDepartment of Pharmacy, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Eun-Ae ShinDepartment of Pharmacy, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Minhyeong LeeDepartment of Pharmacy, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Haesong LeeDepartment of Pharmacy, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Jeong-Hoon LeeDepartment of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
Jung-Hwan YoonDepartment of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
Dae-Geun SongNatural Product Informatics Research Center, Korea Institute of Science and Technology (KIST), Gangneung-si, Gangwon-do, 25451, Republic of Korea.
Semi KimImmunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejon, 34141, Republic of Korea.
Jung Weon LeeDepartment of Pharmacy, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea. jwl@snu.ac.kr.ORCID http://orcid.org/0000-0003-2722-8200
Seoul National University · KRKorea Institute of Science and Technology · KRKorea Research Institute of Bioscience and Biotechnology · KR

Funding

national research foundation of korea 2011-0030001national research foundation of korea NRF-2018M3A9C8020027national research foundation of korea NRF-2020R1A2C3008993national research foundation of korea NRF-2020R1I1A1A01070020national research foundation of korea NRF-2021M3A9D3024752
6 · The paper itself

Abstract

Aberrant extracellular matrix and immune cell alterations within the tumor microenvironment promote the pathological progression of liver carcinogenesis. Although transmembrane 4 L six family member 5 (TM4SF5) is involved in liver fibrosis and cancer, its mechanism avoiding immune surveillance during carcinogenesis remains unknown. We investigated how TM4SF5-mediated signaling caused immune evasion using in vitro primary cells and in vivo liver tissues from genetic or chemically induced mouse models. TM4SF5-transgenic and diethylnitrosamine (DEN)-induced liver cancer mouse models exhibited fibrotic and cancerous livers, respectively, with enhanced TM4SF5, pY

Indexed as

AnimalsCarcinoma, HepatocellularCell Line, TumorHumansKiller Cells, NaturalLiver NeoplasmsMaleMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutTumor MicroenvironmentMembrane ProteinsTM4SF5 protein, humanTM4SF5 protein, mouseImmune checkpointL6 family memberLiver cancerNK cell immune therapySignal transduction

Identifiers

PMID34921636
PMCPMC8739317
OpenAlexW4200271001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.